XML 56 R39.htm IDEA: XBRL DOCUMENT v3.22.2.2
Taxes Payable (Tables)
12 Months Ended
Jun. 30, 2022
Income Tax Disclosure [Abstract]  
Schedule of income taxes and related payables
   June 30,   June 30, 
   2022   2021 
VAT provision  $(384,574)  $(284,940)
Income tax payable   (2,310,360)   (2,395,469)
Other levies   639,237    661,377 
Repatriation tax   29,010,535    29,010,535 
Total  $26,954,838   $26,991,503 

 

Schedule of provision for income taxes
   Years Ended
June 30,
 
   2022   2021 
Current tax – foreign  $(1,291,828)  $2,979,552 
Total  $(1,291,828)  $2,979,552 

 

Schedule of deferred tax assets
   June 30,   June 30, 
   2022   2021 
Deferred tax assets        
Deferred Tax Benefit   35,067,278    36,359,106 
Valuation allowance   (35,067,278)   (36,359,106)
Total deferred tax assets  $
-
    
-
 

 

Schedule of effective income tax rate reconciliation
    China
15% - 25%
    United States
21%
    Total  
                                     
Pretax (loss)   $ (98,939,698 )             (674,813 )           $ (99,614,511 )        
                                                 
Expected income tax expense (benefit)     (24,734,925 )     25.0 %     (141,711 )     21.0 %     (24,876,635 )        
High-tech income benefits on Jinong     765,909       (0.8 )%    
 
      -       765,909          
Loss from subsidiaries in which no benefit is recognized     24,010,666       (24.3 )%    
 
      -       24,010,666          
Change in valuation allowance on deferred tax asset from US tax benefit     (1,291,828 )     1.3 %     141,711       (21.0 )%     (1,150,117 )        
Actual tax expense   $ (1,250,178 )     1.3 %   $ -      
 
%   $ (1,250,178 )     1.3 %

 

   China
15% - 25%
   United States
21%
   Total 
                         
Pretax (loss)  $(122,014,257)        (1,830,369)       $(123,844,626)     
                               
Expected income tax expense (benefit)   (30,503,564)   25.0%   (384,377)   21.0%   (30,887,942)     
High-tech income benefits on Jinong   5,330,679    -4.4%   
-
    
-
    5,330,679      
Loss from subsidiaries in which no benefit is recognized   25,452,867    -20.9%   
-
    
-
    25,452,867      
Change in valuation allowance on deferred tax asset from US tax benefit   2,699,570    -2.2%   384,377    (21.0)%   3,083,947      
Actual tax expense  $2,979,552    -2.4%  $
-
    
 
%  $2,979,552    -2.4%